Logo image of JEN.DE

JENOPTIK AG (JEN.DE) Stock Fundamental Analysis

FRA:JEN - Deutsche Boerse Ag - DE000A2NB601 - Common Stock - Currency: EUR

21.7  -0.42 (-1.9%)

Fundamental Rating

6

Overall JEN gets a fundamental rating of 6 out of 10. We evaluated JEN against 47 industry peers in the Electronic Equipment, Instruments & Components industry. While JEN has a great profitability rating, there are some minor concerns on its financial health. JEN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

JEN had positive earnings in the past year.
JEN had a positive operating cash flow in the past year.
Each year in the past 5 years JEN has been profitable.
JEN had a positive operating cash flow in each of the past 5 years.
JEN.DE Yearly Net Income VS EBIT VS OCF VS FCFJEN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

1.2 Ratios

JEN's Return On Assets of 5.01% is fine compared to the rest of the industry. JEN outperforms 78.72% of its industry peers.
JEN has a Return On Equity of 9.02%. This is in the better half of the industry: JEN outperforms 74.47% of its industry peers.
JEN has a Return On Invested Capital of 6.65%. This is in the better half of the industry: JEN outperforms 74.47% of its industry peers.
JEN had an Average Return On Invested Capital over the past 3 years of 6.49%. This is in line with the industry average of 7.84%.
The last Return On Invested Capital (6.65%) for JEN is above the 3 year average (6.49%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.01%
ROE 9.02%
ROIC 6.65%
ROA(3y)4.1%
ROA(5y)4.33%
ROE(3y)8.46%
ROE(5y)8.38%
ROIC(3y)6.49%
ROIC(5y)6.42%
JEN.DE Yearly ROA, ROE, ROICJEN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10

1.3 Margins

JEN has a better Profit Margin (7.56%) than 89.36% of its industry peers.
JEN's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 12.83%, JEN belongs to the best of the industry, outperforming 91.49% of the companies in the same industry.
In the last couple of years the Operating Margin of JEN has grown nicely.
Looking at the Gross Margin, with a value of 34.19%, JEN is in line with its industry, outperforming 42.55% of the companies in the same industry.
In the last couple of years the Gross Margin of JEN has remained more or less at the same level.
Industry RankSector Rank
OM 12.83%
PM (TTM) 7.56%
GM 34.19%
OM growth 3Y7.43%
OM growth 5Y3.76%
PM growth 3Y0.05%
PM growth 5Y-8.32%
GM growth 3Y-1.07%
GM growth 5Y0.13%
JEN.DE Yearly Profit, Operating, Gross MarginsJEN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

6

2. Health

2.1 Basic Checks

JEN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for JEN remains at a similar level compared to 1 year ago.
The number of shares outstanding for JEN remains at a similar level compared to 5 years ago.
The debt/assets ratio for JEN has been reduced compared to a year ago.
JEN.DE Yearly Shares OutstandingJEN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
JEN.DE Yearly Total Debt VS Total AssetsJEN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 2.68 indicates that JEN is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.68, JEN perfoms like the industry average, outperforming 53.19% of the companies in the same industry.
JEN has a debt to FCF ratio of 4.81. This is a neutral value as JEN would need 4.81 years to pay back of all of its debts.
The Debt to FCF ratio of JEN (4.81) is better than 68.09% of its industry peers.
A Debt/Equity ratio of 0.50 indicates that JEN is not too dependend on debt financing.
JEN has a Debt to Equity ratio (0.50) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 4.81
Altman-Z 2.68
ROIC/WACC1.19
WACC5.6%
JEN.DE Yearly LT Debt VS Equity VS FCFJEN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 2.29 indicates that JEN has no problem at all paying its short term obligations.
JEN has a Current ratio of 2.29. This is in the better half of the industry: JEN outperforms 74.47% of its industry peers.
A Quick Ratio of 1.11 indicates that JEN should not have too much problems paying its short term obligations.
JEN's Quick ratio of 1.11 is in line compared to the rest of the industry. JEN outperforms 57.45% of its industry peers.
Industry RankSector Rank
Current Ratio 2.29
Quick Ratio 1.11
JEN.DE Yearly Current Assets VS Current LiabilitesJEN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 24.55% over the past year.
The Earnings Per Share has been decreasing by -3.62% on average over the past years.
JEN shows a small growth in Revenue. In the last year, the Revenue has grown by 5.81%.
JEN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.02% yearly.
EPS 1Y (TTM)24.55%
EPS 3Y20.89%
EPS 5Y-3.62%
EPS Q2Q%21.05%
Revenue 1Y (TTM)5.81%
Revenue growth 3Y20.09%
Revenue growth 5Y5.02%
Sales Q2Q%3.98%

3.2 Future

Based on estimates for the next years, JEN will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.97% on average per year.
The Revenue is expected to grow by 4.12% on average over the next years.
EPS Next Y2.82%
EPS Next 2Y3.74%
EPS Next 3Y9.31%
EPS Next 5Y10.97%
Revenue Next Year3.96%
Revenue Next 2Y2.86%
Revenue Next 3Y4.15%
Revenue Next 5Y4.12%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
JEN.DE Yearly Revenue VS EstimatesJEN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B
JEN.DE Yearly EPS VS EstimatesJEN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0.5 1 1.5 2 2.5

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 14.66 indicates a correct valuation of JEN.
Based on the Price/Earnings ratio, JEN is valued a bit cheaper than 74.47% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.89, JEN is valued a bit cheaper.
With a Price/Forward Earnings ratio of 12.60, JEN is valued correctly.
JEN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. JEN is cheaper than 68.09% of the companies in the same industry.
JEN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.98.
Industry RankSector Rank
PE 14.66
Fwd PE 12.6
JEN.DE Price Earnings VS Forward Price EarningsJEN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, JEN is valued a bit cheaper than the industry average as 68.09% of the companies are valued more expensively.
68.09% of the companies in the same industry are more expensive than JEN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 12.44
EV/EBITDA 7.67
JEN.DE Per share dataJEN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates JEN does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of JEN may justify a higher PE ratio.
PEG (NY)5.2
PEG (5Y)N/A
EPS Next 2Y3.74%
EPS Next 3Y9.31%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.57%, JEN has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.21, JEN has a dividend in line with its industry peers.
JEN's Dividend Yield is slightly below the S&P500 average, which is at 2.39.
Industry RankSector Rank
Dividend Yield 1.57%

5.2 History

Dividend Growth(5Y)0%
Div Incr Years1
Div Non Decr Years3
JEN.DE Yearly Dividends per shareJEN.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2025 0.1 0.2 0.3

5.3 Sustainability

JEN pays out 23.81% of its income as dividend. This is a sustainable payout ratio.
DP23.81%
EPS Next 2Y3.74%
EPS Next 3Y9.31%
JEN.DE Yearly Income VS Free CF VS DividendJEN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
JEN.DE Dividend Payout.JEN.DE Dividend Payout, showing the Payout Ratio.JEN.DE Dividend Payout.PayoutRetained Earnings

JENOPTIK AG

FRA:JEN (3/27/2025, 11:21:55 AM)

21.7

-0.42 (-1.9%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)03-25 2025-03-25/amc
Inst Owners50.11%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.24B
Analysts83.16
Price Target30.7 (41.47%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.57%
Yearly Dividend0.3
Dividend Growth(5Y)0%
DP23.81%
Div Incr Years1
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.28%
Min EPS beat(2)-3.29%
Max EPS beat(2)13.86%
EPS beat(4)2
Avg EPS beat(4)-4.38%
Min EPS beat(4)-39.49%
Max EPS beat(4)13.86%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.2%
Min Revenue beat(2)-3.02%
Max Revenue beat(2)2.62%
Revenue beat(4)1
Avg Revenue beat(4)-9.46%
Min Revenue beat(4)-34.48%
Max Revenue beat(4)2.62%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-4.38%
EPS NQ rev (1m)-0.11%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-5.29%
Revenue NQ rev (1m)-0.05%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.53%
Valuation
Industry RankSector Rank
PE 14.66
Fwd PE 12.6
P/S 1.12
P/FCF 12.44
P/OCF 6.53
P/B 1.33
P/tB 5.18
EV/EBITDA 7.67
EPS(TTM)1.48
EY6.82%
EPS(NY)1.72
Fwd EY7.94%
FCF(TTM)1.74
FCFY8.04%
OCF(TTM)3.32
OCFY15.3%
SpS19.43
BVpS16.3
TBVpS4.19
PEG (NY)5.2
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.01%
ROE 9.02%
ROCE 10.01%
ROIC 6.65%
ROICexc 6.96%
ROICexgc 14.16%
OM 12.83%
PM (TTM) 7.56%
GM 34.19%
FCFM 8.98%
ROA(3y)4.1%
ROA(5y)4.33%
ROE(3y)8.46%
ROE(5y)8.38%
ROIC(3y)6.49%
ROIC(5y)6.42%
ROICexc(3y)6.82%
ROICexc(5y)7.08%
ROICexgc(3y)15.95%
ROICexgc(5y)14.93%
ROCE(3y)9.78%
ROCE(5y)9.66%
ROICexcg growth 3Y8.69%
ROICexcg growth 5Y0.66%
ROICexc growth 3Y11.42%
ROICexc growth 5Y-6.48%
OM growth 3Y7.43%
OM growth 5Y3.76%
PM growth 3Y0.05%
PM growth 5Y-8.32%
GM growth 3Y-1.07%
GM growth 5Y0.13%
F-Score7
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 4.81
Debt/EBITDA 2.12
Cap/Depr 119.15%
Cap/Sales 8.11%
Interest Coverage 8.12
Cash Conversion 87%
Profit Quality 118.67%
Current Ratio 2.29
Quick Ratio 1.11
Altman-Z 2.68
F-Score7
WACC5.6%
ROIC/WACC1.19
Cap/Depr(3y)108.34%
Cap/Depr(5y)102.54%
Cap/Sales(3y)7.49%
Cap/Sales(5y)6.95%
Profit Quality(3y)95.83%
Profit Quality(5y)98.8%
High Growth Momentum
Growth
EPS 1Y (TTM)24.55%
EPS 3Y20.89%
EPS 5Y-3.62%
EPS Q2Q%21.05%
EPS Next Y2.82%
EPS Next 2Y3.74%
EPS Next 3Y9.31%
EPS Next 5Y10.97%
Revenue 1Y (TTM)5.81%
Revenue growth 3Y20.09%
Revenue growth 5Y5.02%
Sales Q2Q%3.98%
Revenue Next Year3.96%
Revenue Next 2Y2.86%
Revenue Next 3Y4.15%
Revenue Next 5Y4.12%
EBIT growth 1Y17.37%
EBIT growth 3Y29.02%
EBIT growth 5Y8.96%
EBIT Next Year59.81%
EBIT Next 3Y23.76%
EBIT Next 5Y16.12%
FCF growth 1Y76.41%
FCF growth 3Y19.38%
FCF growth 5Y-3.19%
OCF growth 1Y45.29%
OCF growth 3Y22.92%
OCF growth 5Y4.33%